Lexicon Pharmaceuticals | 股本和储备



金融业
股票价格
USD
资产
USD 225.58M
现金及等价物
USD 21.36M
销售成本
USD 17.81M
流动资产
USD 145.08M
流动负债
USD 34.84M
债务
USD 99.27M
股息收益率
0
EBIT
USD -49.63M
EBITDA
USD -49.48M
员工
285
EPS每股收益
USD -0.17
股本和储备
USD 129.44M
销售毛利
USD -16.16M
债务利息支出
USD 2.21M
贷款资金
USD 56.11M
市值
USD 384.1M
净收入
USD -53.43M
营业费用
USD 57M
营业利润
USD -55.35M
普通股股本
USD 245K
PE价格收益
12.44
税前利润
USD -53.43M
销售收入
USD 1.65M
销售和管理费用
USD 39.19M
股票
USD 168K
贸易债权人
USD 5.9M
应收帐款人
USD 2.62M


股本和储备 更改 日
Abbott USD 52.13B 1.3B 2025-12
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Coherus Biosciences USD 87.77M 32.05M 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Illumina USD 2.72B 342M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
J&J USD 78.47B 0 2025-09
Lexicon Pharmaceuticals USD 129.44M 6.41M 2025-06
MacroGenics USD 67M 20.38M 2025-09
MannKind USD -51.02M 6.47M 2025-12
Merck USD 51.85B 2.79B 2025-09
Moderna USD 8.65B 680M 2025-12
Novartis USD 44.75B 2.7B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12


Lexicon Pharmaceuticals 股本和储备 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.